Computerized Cognitive Training for Psychosis
(STEP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests how computerized cognitive training can help people with psychosis improve their ability to process information about their surroundings. Participants complete tasks on a computer while researchers monitor their brain activity. The trial includes two types of training: one focuses on recognizing visual patterns, and the other on tracking rules to make decisions. It suits individuals diagnosed with a psychotic disorder who have been stable for at least a month. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could enhance cognitive therapies for psychosis.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the study team or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that computerized cognitive training (CCT) is generally safe. It has been successfully used with individuals who have conditions like depression and schizophrenia. This training aims to improve thinking skills and has demonstrated positive results in past studies.
For Perceptual Discrimination Training, evidence from similar methods suggests they are well-tolerated. Participants improve their attention and ability to distinguish important information with minimal side effects.
Similarly, Cognitive Control Training, which helps maintain focus and improve memory, has been used safely in various settings. This training adapts to the participant's performance, making it challenging yet manageable.
Overall, both training methods in this trial are considered safe based on past research and experiences.12345Why are researchers excited about this trial?
Researchers are excited about the computerized cognitive training for psychosis because it offers a novel approach by directly targeting cognitive deficits, unlike traditional treatments that mainly focus on managing symptoms with medications like antipsychotics. The Perceptual Discrimination Training improves signal-to-noise resolution and attentional control through adaptive visual exercises, potentially enhancing how patients process and respond to visual stimuli. On the other hand, Cognitive Control Training focuses on maintaining cognitive context and working memory, adapting the difficulty based on the participant's performance to strengthen mental flexibility and decision-making. These targeted cognitive enhancements could lead to improved daily functioning for individuals with psychosis, addressing aspects that current treatments may not fully cover.
What evidence suggests that this trial's treatments could be effective for psychosis?
Research has shown that computer-based brain exercises can enhance thinking and memory in people with psychosis. In this trial, participants will engage in different training methods. One method, Perceptual Discrimination Training, helps individuals see and understand visual information more clearly and has been linked to moderate improvements in overall thinking skills, particularly in memory and information use. Another method, Cognitive Control Training, focuses on improving the ability to hold and use information for decision-making, aiding concentration and mental flexibility. Both training types adjust to the user's performance, ensuring the exercises remain challenging yet manageable.23678
Who Is on the Research Team?
Sophia Vinogradov, M.D.
Principal Investigator
University of Minnesota
Angus MacDonald III, Ph.D.
Principal Investigator
University of Minnesota
Are You a Good Fit for This Trial?
This trial is for individuals aged 15-40 who have been diagnosed with psychotic illnesses like schizophrenia, and also for young adults without psychiatric diagnoses. Participants must speak English, have an IQ of 70 or above, and be able to give informed consent. Pregnant individuals, those with major neurological disorders or medical conditions that could interfere with the study, recent substance dependence cases, or significant head injuries are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete interviews, self-report questionnaires, neurocognitive assessments, and imaging with EEG-fMRI
Follow-up Assessment
Participants repeat the baseline assessments after 6 months to evaluate changes in clinical and experimental measures
Cognitive Training
Participants undergo 10 hours of computerized cognitive training over a 3-6 week period
Post-Intervention Assessment
Participants complete post-intervention assessments similar to baseline, immediately after training
Long-term Follow-up
Participants are monitored for changes in symptoms and cognitive performance 12 months from enrollment
What Are the Treatments Tested in This Trial?
Interventions
- Computerized Cognitive Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator